1195 Discovery of CBO421, a first-in-class drug Fc-conjugate (DFC), targeting CD73 in cancer

• María Hernández,
• Simon Dohrmann,
• James Levin,
• Nicholas Dedeic,
• Amanda Almaguer,
• Doug Zuill,
• Elizabeth Abelovski,
• Rajvir Grewal,
• Joanne Fortier,
• Qiping Zhao,
• Karin Amundson,
• Madison Moniz,
• Hongyuan Chen,
• Dhanya Panicker,
• Thanh Lam,
• Thomas P Brady,
• Allen Borchardt,
• Jason N Cole,
• Leslie W Tari

Affiliations

María Hernández

13 Department of Pediatrics, Hospital Materno Infantil de Las Palmas, Las Palmas, Spain

Simon Dohrmann

Cidara Therapeutics, San Diego, CA, USA

James Levin

Cidara Therapeutics, San Diego, CA, USA

Nicholas Dedeic

Cidara Therapeutics, San Diego, CA, USA

Amanda Almaguer

Cidara Therapeutics, San Diego, CA, USA

Doug Zuill

Cidara Therapeutics, San Diego, CA, USA

Elizabeth Abelovski

Cidara Therapeutics, San Diego, CA, USA

Rajvir Grewal

Cidara Therapeutics, San Diego, CA, USA

Joanne Fortier

Cidara Therapeutics, San Diego, CA, USA

Qiping Zhao

Cidara Therapeutics, San Diego, CA, USA

Karin Amundson

Cidara Therapeutics, San Diego, CA, USA

Madison Moniz

Cidara Therapeutics, San Diego, CA, USA

Hongyuan Chen

Cidara Therapeutics, San Diego, CA, USA

Dhanya Panicker

Cidara Therapeutics, San Diego, CA, USA

Thanh Lam

Cidara Therapeutics, San Diego, CA, USA

Thomas P Brady

Cidara Therapeutics, San Diego, CA, USA

Allen Borchardt

Cidara Therapeutics, San Diego, CA, USA

Jason N Cole

Cidara Therapeutics, San Diego, CA, USA

Leslie W Tari

Cidara Therapeutics, San Diego, CA, USA